Back
Sarepta Therapeutics Vs. Upstart Holdings Industry Stock Comparison
Sell
32
SRPT
Sarepta Therapeutics
Last Price:
112.44
Seasonality Move:
19.2%
Buy
78
UPST
Upstart Holdings
Last Price:
67.80
Seasonality Move:
-6.61%
Sell
32
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $114.29. The Score for SRPT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
78
Upstart Holdings (UPST)
is a Buy
Is Upstart Holdings a Buy, Sell or Hold?
- The current Upstart Holdings [UPST] share price is $69.43. The Score for UPST is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
- UPST is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $114.29
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
UPST Stock Price Chart
What is Upstart Holdings's stock price today?
-
The Upstart Holdings share price today is $69.43
The current trend is moderately bullish and UPST is experiencing slight buying pressure.
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.96 | Sell |
Relative Strength Index (14 RSI): | 32.44 | Sell |
Chaikin Money Flow: | -1022061 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (120.42 - 129.34) | Sell |
Bollinger Bands (100): | (123.32 - 147.22) | Sell |
UPST Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.45 | Buy |
Relative Strength Index (14 RSI): | 65.99 | Buy |
Chaikin Money Flow: | 3634701 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.12 - 62.46) | Buy |
Bollinger Bands (100): | (26.33 - 49.61) | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 121.68 | Sell |
20-day SMA: | 125.65 | Sell |
50-day SMA: | 125.36 | Sell |
200-day SMA: | 130.57 | Sell |
8-day EMA: | 120.95 | Sell |
20-day EMA: | 123.72 | Sell |
50-day EMA: | 126.59 | Sell |
200-day EMA: | 127.45 | Sell |
UPST Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 60.44 | Buy |
20-day SMA: | 55.1 | Buy |
50-day SMA: | 45.63 | Buy |
200-day SMA: | 31.88 | Buy |
8-day EMA: | 64.01 | Buy |
20-day EMA: | 56.35 | Buy |
50-day EMA: | 48.17 | Buy |
200-day EMA: | 36.18 | Buy |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.55 per share.
Upstart Holdings Earnings Growth & UPST Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and an increase next year of $0.98 per share.
Sarepta Therapeutics Technical Analysis
Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Upstart Holdings Technical Analysis
Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |